16/10/2007 - 15:29

Solbec's Coramsine wins tick from one US doctor

16/10/2007 - 15:29

Bookmark

Save articles for future reference.

Osborne Park-based Solbec Pharmaceuticals Ltd has had a small win, with the United States Food and Drug Administration allowing the use of its Coramsine cancer treatment under a Physician's Investigational New Drug application.

To read our articles you will need to either login or subscribe.

STANDING BY BUSINESS. TRUSTED BY BUSINESS.

Subscription Options